American College of Cardiology

MARCH 12, 2025

The Heart Valve Collaboratory has proposed a framework to standardize best practices for using multimodality imaging in transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR), in a State-of-the-Art Review.

Heart Valves 60

Heart Valves TAVR Aortic valve Best Practices 60

American College of Cardiology

JULY 18, 2024

What are the national trends in utilization of leadless pacemaker implantation following transcatheter aortic valve replacement (TAVR) and its performance compared with transvenous pacemakers?

TAVR 54

TAVR Pacemaker Aortic valve Aortic 54

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 56

TAVR Aortic Stenosis Aortic valve 56

American College of Cardiology

APRIL 4, 2024

The goal of the VIVA trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis and a small aortic annulus.

Aortic valve 46

Aortic valve Aortic Stenosis TAVR 46

American College of Cardiology

OCTOBER 28, 2024

The goal of the TAVR UNLOAD trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with clinical surveillance among patients with chronic systolic heart failure and moderate aortic stenosis (stage B aortic stenosis).

Aortic valve 46

Aortic valve Heart Failure Aortic TAVR 46

American College of Cardiology

NOVEMBER 5, 2024

What are outcomes among patients younger than 65 years who received transcatheter aortic valve replacement (TAVR) using a balloon-expandable valve compared to patients aged 65-80 years?

TAVR 49

TAVR Aortic valve Outcomes Aortic 49

American College of Cardiology

DECEMBER 4, 2024

Does measured or predicted prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) affect all-cause mortality at 2 years?

TAVR 46

TAVR Aortic valve Outcomes Aortic 46

American College of Cardiology

AUGUST 5, 2024

What is the effect of the time interval between transcatheter aortic valve replacement (TAVR) and noncardiac surgery (NCS) (Δt) on the perioperative risk of major adverse events (MAEs)?

TAVR 46

TAVR Aortic valve Aortic Article 46

American College of Cardiology

NOVEMBER 6, 2024

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients.

TAVR 49

TAVR Blood Pressure Aortic valve Aortic 49

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 49

TAVR Aortic valve Aortic Stroke 49

American College of Cardiology

OCTOBER 28, 2024

Two separate late-breaking clinical trials – EARLY TAVR and EVOLVED – presented at TCT 2024 explore whether early aortic valve intervention improves outcomes in patients with asymptomatic aortic stenosis (AS).

TAVR 49

TAVR Aortic valve Aortic Stenosis 49

American College of Cardiology

AUGUST 6, 2024

The following are key points to remember from a state-of-the-art guide to transcatheter aortic valve (TAV) design and systematic planning for a redo-TAV (TAV-in-TAV) procedure.

Aortic valve 64

Aortic valve TAVR Aortic Article 64

American College of Cardiology

AUGUST 21, 2024

Among patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve (BEV), what are the 3-year clinical outcomes associated with a small (20 mm) compared to a larger (≥23 mm) device, and is there a relationship between the discharge echocardiographic (echo) mean gradient (MG) and measured or predicted thresholds (..)

TAVR 49

TAVR Aortic valve Outcomes Aortic 49

American College of Cardiology

FEBRUARY 17, 2024

Alain Cribier, MD, FACC, the man who pioneered the first transcatheter aortic valve replacement (TAVR), passed away on Feb. 16 at the age of 79.

Aortic valve 75

Aortic valve TAVR Aortic Article 75

Circulation

NOVEMBER 11, 2024

Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 In the TIA case, there was no evidence of a significant difference between TAVR and SAVR in the risk of having a transient ischemic attack within 30 days following surgery (OR 0.93, 95% CI 0.24 to 1.17, p=0.30, I2 3%).

Aortic valve 40

Aortic valve Aortic TAVR Stroke 40

European Journal of Heart Failure

JANUARY 31, 2024

TAVR in heart failure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The prognostic covariates and optimal timing of TAVR in patients with less than severe AS remain unclear.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

American College of Cardiology

NOVEMBER 6, 2024

What are the contemporary characteristics, trends, and outcomes of intravascular lithotripsy (IVL)-assisted transfemoral (TF) transcatheter aortic valve replacement (TAVR) in the United States?

TAVR 43

TAVR Aortic valve Outcomes Aortic 43

American College of Cardiology

FEBRUARY 8, 2024

Is there a relationship between site-level volumes and outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER)?

TAVR 46

TAVR Aortic valve Outcomes Hospital 46

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV.

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

American College of Cardiology

JANUARY 6, 2025

Subclinical leaflet thrombosis (SLT) has raised concerns about the long-term durability and outcomes of transcatheter aortic valve replacement (TAVR). Clinical valve thrombosis (CVT) is a rare complication after TAVR with an incidence of 0.62.8%

Thrombosis 40

Thrombosis TAVR Aortic valve Aortic 40

American College of Cardiology

DECEMBER 20, 2024

The goal of the SOLVE-TAVI trial was to compare the safety and efficacy of the Edwards Sapien S3 valve vs. Medtronics CoreValve among patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis.

Aortic valve 43

Aortic valve Aortic TAVR Stenosis 43

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 56

Aortic valve Coronary Artery Disease TAVR Aortic 56

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

The presence of cardiac amyloidosis negatively affects the outcome of patients with aortic stenosis, these patients undergo transcatheter aortic valve replacement (TAVR) with increasing frequency and have a significantly higher overall mortality rate than patients with aortic stenosis alone.

Stenosis 69

Stenosis Aortic TAVR Aortic valve 69

American College of Cardiology

OCTOBER 29, 2024

The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.

Aortic valve 43

Aortic valve Aortic TAVR Stroke 43

American College of Cardiology

JULY 2, 2024

The goal of the LANDMARK trial was to evaluate transcatheter aortic valve replacement (TAVR) with the Myval prosthesis compared with a contemporary prosthesis among patients with symptomatic severe aortic stenosis.

Heart Valves 49

Heart Valves Aortic valve TAVR Aortic 49

American College of Cardiology

APRIL 7, 2024

The goal of the SMART trial was to evaluate a self-expanding valve compared with a balloon-expandable valve among patients with aortic stenosis and a small aortic annulus undergoing treatment with transcatheter aortic valve replacement (TAVR).

Aortic valve 49

Aortic valve TAVR Aortic Stenosis 49

American College of Cardiology

MARCH 29, 2024

has seen a 25-fold increase in the use of TAVR, with more than 100,000 performed annually. This technique is now employed in approximately 85% of all isolated aortic valve replacements. In the past decade, the U.S. Despite this growth, there are notable gaps in the evidence.

Bicuspid/Mitral 46

Bicuspid/Mitral Aortic Aortic valve TAVR 46

American College of Cardiology

MARCH 29, 2024

My patient is 59 years old, has symptomatic severe aortic stenosis (AS) with a bicuspid aortic valve (BAV), and his proximal aorta is 3.6 He has no important comorbidities and was referred for advice as to whether he should have a surgical (SAVR) or transcatheter (TAVR) aortic valve replacement.

Aortic valve 40

Aortic valve Bicuspid/Mitral TAVR Aortic 40

Dr. S. Venkatesan MD

FEBRUARY 9, 2024

Hans Gustav Hørsted Thyregod, Troels Højsgaard Jørgensen, Nikolaj Ihlemann, Daniel Andreas Steinbrüchel, Henrik Nissen, Bo Juel Kjeldsen, Petur Petursson, Ole De Backer, Peter Skov Olsen, Lars Søndergaard, Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial, European Heart Journal , 2024;, ehae043 , [link] 2.

Aortic valve 52

Aortic valve Aortic Academic Physiology 52

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

The diagnostic coronary angiogram identified only minimal coronary artery disease, but there was a severely calcified, ‘immobile’ aortic valve. Aortic angiogram did not reveal aortic dissection. If you see this, you should Doppler the valve. Aortic valve surgery as an emergency procedure.

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

Cardiology Update

JANUARY 31, 2024

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for older patients suffering from severe aortic valve stenosis, surpassing the annual patient count of those opting for surgical aortic valve replacement. years, with 56% being women. in 2007-2010 to 5.5%

TAVR 118

TAVR Aortic valve Outcomes Aortic 118

Cardiology Update

FEBRUARY 6, 2024

Within the realm of transcatheter aortic valve replacement (TAVR), stroke emerges as a recognized adverse event, manifesting at various stages during and after the procedure. Previous studies extensively delved into short-term incidence, trends, and clinical outcomes related to TAVR-associated stroke. at 5 years.

TAVR 111

TAVR Stroke Strokes Aortic valve 111

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. vs. 4.0%, p=0.36) or one year (17.5% vs. 3.3%, p=0.18).

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

American College of Cardiology

APRIL 8, 2024

TAVR was found to bring no increased risks and was associated with substantially decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to results from the DEDICATE-DZHK6 study presented during a Late-Breaking Clinical Trial session at ACC.24

TAVR 52

TAVR Aortic valve Aortic Stroke 52

American College of Cardiology

OCTOBER 29, 2024

In women with symptomatic, severe aortic stenosis (AS), TAVR with the balloon-expandable valve was superior to surgical aortic valve replacement in terms of the composite rate of death, stroke and rehospitalization at one-year follow-up, according to a pooled analysis of patient-level data from RHEIA and PARTNER 3 trials presented at TCT 2024.

TAVR 46

TAVR Aortic valve Aortic Stenosis 46

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

Abstract: Transcatheter aortic valve replacement (TAVR) is an interventional procedure performed in patients with severe aortic stenosis and often required perioperative antiplatelet therapy. Most previous studies have focused on antiplatelet therapy following TAVR.

Aortic valve 40

Aortic valve Aortic TAVR Myocardial Infarction 40

American College of Cardiology

FEBRUARY 18, 2025

The EARLY TAVR trial results demonstrate that early transcatheter aortic valve implantation in patients with asymptomatic severe aortic stenosis is superior to clinical surveillance in significantly reducing the composite primary outcome of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 58

Stenosis Aortic Aortic valve TAVR 58